PMA device
Therapy Cool Path
Irvine Biomedical, Inc. · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD, Class III) · First FDA decision Jun 12, 2009, newest Nov 2, 2020Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
9
Naming "Therapy Cool Path"
MAUDE reports
53
Brand "Therapy Cool Path", since 2015
PubMed studies
0
Mentioning "Therapy Cool Path"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Therapy Cool Path
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Therapy Cool Path, Safire BLU, Safire BLU SP, and Therapy Cool Path SP Ablation CathetersPMA supplement
P060019-S048 · Decided Nov 2, 2020 · 112 days after receipt · Normal 180 Day Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
- THERAPY COOL PATH ABLATION CATHETERPMA supplement
P060019-S013 · Decided Dec 3, 2010 · 95 days after receipt · Normal 180 Day Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
P060019-S005 · Decided Jun 12, 2009 · 333 days after receipt · Normal 180 Day Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Therapy Cool Path", any status and sponsor, newest update first.
- Non-pharmacological Care for Depression in Cancer Patients Using VR and TMSPivotal-lookingRecruiting
University Hospital of FerraraAcademic, hospital or other
NCT06589544 · 100 participants (planned) · Start Aug 21, 2024 · Primary completion Dec 31, 2026
Device: Virtual Reality-based Cognitive Remediation (VR-COG) + Treatment as Usual (TAU); Repetitive transcranial magnetic stimulation (rTMS) + Treatment as usual (TAU) · For: Depressive Symptoms; Quality of Life; Cognitive Impairment
Sites: Ferrara, Italy; Cagliari, Italy
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation TrialPivotal-lookingCompleted
Mayo ClinicAcademic, hospital or other
NCT00911508 · 2,204 participants · Start Nov 13, 2009 · Primary completion Dec 31, 2017
Device: Left atrial ablation · For: Atrial Fibrillation; Arrhythmia
Sites: Little Rock, Arkansas; Los Angeles, California; Sacramento, California · 118 sites in all
Abbott Medical DevicesPublic (ABT)
NCT01907828 · 61 participants · Start Apr 15, 2014 · Primary completion Oct 15, 2018
Device: Renal Artery Ablation; Cardiac Ablation · For: Persistent Atrial Fibrillation; Paroxysmal Atrial Fibrillation; Hypertension
Sites: Dresden, Germany; Leipzig, Germany
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Therapy Cool Path", and for the whole product code for context.
This brand
53 reports: 10 malfunction, 40 injury, 3 death
Whole product code OAD
3,979 reports: 1,924 malfunction, 1,908 injury, 137 death
Newest reports for this brand
2030404-2025-00001 · Received Jan 9, 2025
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Vascular Problem
2030404-2024-00022 · Received Mar 12, 2024
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event
Patient problem as coded: Perforation of Esophagus; Cardiac Perforation; No Clinical Signs, Symptoms or Conditions
2030404-2024-00024 · Received Mar 12, 2024
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event
Patient problem as coded: Stroke/CVA; Nerve Damage; Cardiac Perforation; No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1032-2012 · Started Jan 5, 2012 · Posted by FDA Feb 14, 2012
Reason given: Two St Jude Medical 1500T9 RF Generator units were distributed to customers while still under FDA review as part of a PMA supplement to the approved PMA applications.
Cause as FDA categorized it: Vendor change control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Published research
The most relevant PubMed records for "Therapy Cool Path"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OAD.
- Blazer Open-Irrigated Ablation CatheterBoston Scientific Corp · PMA 2025
- Blazer II XP Cardiac Ablation Catheter and CableBoston Scientific · PMA 2025
- FlexAbility Ablation Catheter, Sensor EnabledAbbott Medical · PMA 2025
- Therapy Dual 8 Catheter,therapy 8MM Thermistor Ablation CatheterIrvine Biomedical,Inc.(Ibi) · PMA 2016
- THERMOCOOL SMARTTOUCH® SF CatheterBiosense Webster, Inc. · PMA 2026
- Therapy Cool Path DuoAbbott Medical · PMA 2020
- VISITAG SURPOINT External Processing Unit (EPU)Biosense Webster, Inc. · PMA 2026
- Safire TX Ablation CatheterIrvine Biomedical,Inc.(Ibi) · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.